{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:01:12Z","timestamp":1787169672107,"version":"build-2736575974"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12885-018-5194-8","type":"journal-article","created":{"date-parts":[[2018,12,21]],"date-time":"2018-12-21T20:27:59Z","timestamp":1545424079000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["The interactions of novel mononuclear platinum-based complexes with DNA"],"prefix":"10.1186","volume":"18","author":[{"given":"Ben W.","family":"Johnson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark W.","family":"Burgess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice R.","family":"Aldrich-Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0902-6322","authenticated-orcid":false,"given":"Mark D.","family":"Temple","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,12,22]]},"reference":[{"key":"5194_CR1","doi-asserted-by":"publisher","first-page":"251","DOI":"10.2174\/1568011053765967","volume":"5","author":"Y Sedletska","year":"2005","unstructured":"Sedletska Y, Giraud-Panis MJ, Malinge JM. Cisplatin is a DNA-damaging antitumour compound triggering multifactorial biochemical responses in cancer cells: importance of apoptotic pathways. Curr Med Chem Anticancer Agents. 2005;5:251\u201365. https:\/\/doi.org\/10.2174\/1568011053765967 .","journal-title":"Curr Med Chem Anticancer Agents"},{"key":"5194_CR2","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0163-7258(87)90009-X","volume":"34","author":"A Eastman","year":"1987","unstructured":"Eastman A. The formation, isolation and characterization of DNA adducts produced by anticancer platinum complexes. Pharmacol Ther. 1987;34:155\u201366. https:\/\/doi.org\/10.1016\/0163-7258(87)90009-X .","journal-title":"Pharmacol Ther"},{"key":"5194_CR3","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nrc2167","volume":"7","author":"L Kelland","year":"2007","unstructured":"Kelland L. The resurgence of platinum-based cancer chemotherapy. Nat Rev Cancer. 2007;7:573\u201384. https:\/\/doi.org\/10.1038\/nrc2167 .","journal-title":"Nat Rev Cancer"},{"key":"5194_CR4","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1021\/bi00324a025","volume":"24","author":"AMJ Fichtinger-Schepman","year":"1985","unstructured":"Fichtinger-Schepman AMJ, Van der Veer JL, Den Hartog JHJ, Lohman PHM, Reedijk J. Adducts of the antitumor drug cis-diamminedichloroplatinum (II) with DNA: formation, identification, and quantitation. Biochemistry. 1985;24:707\u201313. https:\/\/doi.org\/10.1021\/bi00324a025 .","journal-title":"Biochemistry"},{"key":"5194_CR5","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1021\/cr980421n","volume":"99","author":"ER Jamieson","year":"1999","unstructured":"Jamieson ER, Lippard SJ. Structure, recognition, and processing of cisplatin- DNA adducts. Chem Rev. 1999;99:2467\u201398. https:\/\/doi.org\/10.1021\/cr980421n .","journal-title":"Chem Rev"},{"key":"5194_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0079-6603(02)71040-4","volume":"71","author":"V Brabec","year":"2002","unstructured":"Brabec V. DNA modifications by antitumor platinum and ruthenium compounds: their recognition and repair. Prog Nucleic Acid Res Mol Biol. 2002;71:1\u201368 https:\/\/doi.org\/10.1016\/S0079-6603(02)71040-4 .","journal-title":"Prog Nucleic Acid Res Mol Biol"},{"key":"5194_CR7","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/cbic.200400287","volume":"6","author":"OD Scharer","year":"2005","unstructured":"Scharer OD. DNA interstrand crosslinks: natural and drug-induced DNA adducts that induce unique cellular responses. Chembiochem. 2005;6:27\u201332. https:\/\/doi.org\/10.1002\/cbic.200400287 .","journal-title":"Chembiochem"},{"key":"5194_CR8","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1021\/cr040478b","volume":"106","author":"DM Noll","year":"2006","unstructured":"Noll DM, Mason TM, Miller PS. Formation and repair of Interstrand cross-links in DNA. Chem Rev. 2006;106:277\u2013301. https:\/\/doi.org\/10.1021\/cr040478b .","journal-title":"Chem Rev"},{"key":"5194_CR9","doi-asserted-by":"publisher","unstructured":"Moyzis RK, Buckingham JM, Cram LS, Dani M, Deaven LL, Jones MD, Meyne J, Ratliff RL, Wu JR. A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes. Proc Natl Acad Sci USA. 1988;85:6622\u20136 https:\/\/doi.org\/10.1073\/pnas.85.18.6622 .","DOI":"10.1073\/pnas.85.18.6622"},{"key":"5194_CR10","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1126\/science.279.5349.349","volume":"279","author":"AG Bodnar","year":"1998","unstructured":"Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB, Harley CB, Shay JW, Lichtsteiner S, Wright WE. Extension of life-span by introduction of telomerase into normal human cells. Science. 1998;279:349\u201352. https:\/\/doi.org\/10.1126\/science.279.5349.349 .","journal-title":"Science"},{"key":"5194_CR11","doi-asserted-by":"publisher","first-page":"4237","DOI":"10.1093\/nar\/28.21.4237","volume":"28","author":"JN Burstyn","year":"2000","unstructured":"Burstyn JN, Heiger-Bernays WJ, Cohen SM, Lippard SJ. Formation of cis-diamminedichloroplatinum(II) 1,2-intrastrand cross-links on DNA is flanking-sequence independent. Nucleic Acids Res. 2000;28:4237\u201343. https:\/\/doi.org\/10.1093\/nar\/28.21.4237 .","journal-title":"Nucleic Acids Res"},{"key":"5194_CR12","doi-asserted-by":"publisher","first-page":"177","DOI":"10.2174\/187152012800228742","volume":"12","author":"V Murray","year":"2012","unstructured":"Murray V, Kandasamy N. The sequence specificity of the anti-tumour drug, cisplatin, in telomeric DNA sequences compared with consecutive guanine DNA sequences. Anti Cancer Agents Med Chem. 2012;12:177\u201381. https:\/\/doi.org\/10.2174\/187152012800228742 .","journal-title":"Anti Cancer Agents Med Chem"},{"key":"5194_CR13","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/j.bmcl.2012.12.021","volume":"23","author":"HT Nguyen","year":"2013","unstructured":"Nguyen HT, Galea AM, Murray V. The interaction of cisplatin with a human telomeric DNA sequence containing seventeen tandem repeats. Bioorg Med Chem Lett. 2013;23:1041\u20135. https:\/\/doi.org\/10.1016\/j.bmcl.2012.12.021 .","journal-title":"Bioorg Med Chem Lett"},{"key":"5194_CR14","doi-asserted-by":"publisher","first-page":"6345","DOI":"10.1158\/1078-0432.CCR-06-0486","volume":"12","author":"BM Unryn","year":"2006","unstructured":"Unryn BM, Hao D, Gluck S, Riabowol KT. Acceleration of telomere loss by chemotherapy is greater in older patients with locally advanced head and neck cancer. Clin Cancer Res. 2006;12:6345\u201350. https:\/\/doi.org\/10.1158\/1078-0432.CCR-06-0486 .","journal-title":"Clin Cancer Res"},{"key":"5194_CR15","doi-asserted-by":"publisher","first-page":"7368","DOI":"10.1021\/ja00230a017","volume":"110","author":"SE Sherman","year":"1988","unstructured":"Sherman SE, Gibson D, Wang AHJ, Lippard SJ. Crystal and molecular structure of cis-[Pt(NH3)2[d(pGpG)]], the principal adduct formed by cis-diamminedichloroplatinum(II) with DNA. J Am Chem Soc. 1988;110:7368\u201381. https:\/\/doi.org\/10.1021\/ja00230a017 .","journal-title":"J Am Chem Soc"},{"key":"5194_CR16","doi-asserted-by":"publisher","first-page":"4715","DOI":"10.1093\/nar\/10.15.4715","volume":"10","author":"JH Hartog den","year":"1982","unstructured":"den Hartog JH, Altona C, Chottard JC, Girault JP, Lallemand JY, de Leeuw FA, Marcelis AT, Reedijk J. Conformational analysis of the adduct cis-[Pt(NH3)2 d(GpG)]+ in aqueous solution. A high field (500-300 MHz) nuclear magnetic resonance investigation. Nucleic Acids Res. 1982;10:4715\u201330 https:\/\/doi.org\/10.1093\/nar\/10.15.4715 .","journal-title":"Nucleic Acids Res"},{"key":"5194_CR17","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1039\/b609495c","volume":"36","author":"AD Richards","year":"2007","unstructured":"Richards AD, Rodger A. Synthetic metallomolecules as agents for the control of DNA structure. Chem Soc Rev. 2007;36:471\u201383. https:\/\/doi.org\/10.1039\/b609495c .","journal-title":"Chem Soc Rev"},{"key":"5194_CR18","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1093\/jnci\/88.19.1346","volume":"88","author":"SG Chaney","year":"1996","unstructured":"Chaney SG, Sancar A. DNA repair: enzymatic mechanisms and relevance to drug response. J Natl Cancer Inst. 1996;88:1346\u201360 https:\/\/doi.org\/10.1093\/jnci\/88.19.1346 .","journal-title":"J Natl Cancer Inst"},{"key":"5194_CR19","first-page":"4899","volume":"62","author":"T Furuta","year":"2002","unstructured":"Furuta T, Ueda T, Aune G, Sarasin A, Kraemer KH, Pommier Y. Transcription-coupled nucleotide excision repair as a determinant of cisplatin sensitivity of human cells. Cancer Res. 2002;62:4899\u2013902 http:\/\/cancerres.aacrjournals.org\/content\/62\/17\/4899 .","journal-title":"Cancer Res"},{"key":"5194_CR20","doi-asserted-by":"publisher","first-page":"10394","DOI":"10.1073\/pnas.91.22.10394","volume":"91","author":"JC Huang","year":"1994","unstructured":"Huang JC, Zamble DB, Reardon JT, Lippard SJ, Sancar A. HMG-domain proteins specifically inhibit the repair of the major DNA adduct of the anticancer drug cisplatin by human excision nuclease. Proc Natl Acad Sci U S A. 1994;91:10394 https:\/\/doi.org\/10.1073\/pnas.91.22.10394 .","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5194_CR21","doi-asserted-by":"publisher","first-page":"5768","DOI":"10.1073\/pnas.100108697","volume":"97","author":"Q He","year":"2000","unstructured":"He Q, Liang CH, Lippard SJ. Steroid hormones induce HMG1 overexpression and sensitize breast cancer cells to cisplatin and carboplatin. Proc Natl Acad Sci U S A. 2000;97:5768\u201372. https:\/\/doi.org\/10.1073\/pnas.100108697 .","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5194_CR22","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1517\/13543780903114168","volume":"18","author":"T Boulikas","year":"2009","unstructured":"Boulikas T. Clinical overview on Lipoplatin: a successful liposomal formulation of cisplatin. Expert Opin Investig Drugs. 2009;18:1197\u2013218. https:\/\/doi.org\/10.1517\/13543780903114168 .","journal-title":"Expert Opin Investig Drugs"},{"key":"5194_CR23","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1016\/S0006-2952(97)81490-6","volume":"52","author":"O Rixe","year":"1996","unstructured":"Rixe O, Ortuzar W, Alvarez M, Parker R, Reed E, Paull K, Fojo T. Oxaliplatin, tetraplatin, cisplatin, and carboplatin: spectrum of activity in drug-resistant cell lines and in the cell lines of the National Cancer Institute's anticancer drug screen panel. Biochem Pharmacol. 1996;52:1855\u201365. https:\/\/doi.org\/10.1016\/S0006-2952(97)81490-6 .","journal-title":"Biochem Pharmacol"},{"key":"5194_CR24","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s10120-011-0007-7","volume":"14","author":"F Montagnani","year":"2011","unstructured":"Montagnani F, Turrisi G, Marinozzi C, Aliberti C, Fiorentini G. Effectiveness and safety of oxaliplatin compared to cisplatin for advanced, unresectable gastric cancer: a systematic review and meta-analysis. Gastric Cancer. 2011;14:50\u20135. https:\/\/doi.org\/10.1007\/s10120-011-0007-7 .","journal-title":"Gastric Cancer"},{"key":"5194_CR25","doi-asserted-by":"publisher","first-page":"5474","DOI":"10.1021\/jm9007104","volume":"52","author":"AM Krause-Heuer","year":"2009","unstructured":"Krause-Heuer AM, Gru nert R, Ku hne S, Buczkowska M, Wheate NJ, Le Pevelen DD, Boag LR, Fisher DM, Kasparkova J, Malina J. Studies of the mechanism of action of platinum (II) complexes with potent cytotoxicity in human cancer cells. J Med Chem. 2009;52:5474\u201384. https:\/\/doi.org\/10.1021\/jm9007104 .","journal-title":"J Med Chem"},{"key":"5194_CR26","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.1093\/nar\/19.11.2929","volume":"19","author":"M Ponti","year":"1991","unstructured":"Ponti M, Forrow SM, Souhami RL, D'Incalci M, Hartley JA. Measurement of the sequence specificity of covalent DNA modification by antineoplastic agents using Taq DNA polymerase. Nucleic Acids Res. 1991;19:2929\u201333 https:\/\/doi.org\/10.1093\/nar\/19.11.2929 .","journal-title":"Nucleic Acids Res"},{"key":"5194_CR27","doi-asserted-by":"crossref","first-page":"18805","DOI":"10.1016\/S0021-9258(19)37032-2","volume":"267","author":"V Murray","year":"1992","unstructured":"Murray V, Motyka H, England PR, Wickham G, Lee HH, Denny WA, McFadyen WD. The use of Taq DNA polymerase to determine the sequence specificity of DNA damage caused by cis-diamminedichloroplatinum(II), acridine-tethered platinum(II) diammine complexes or two analogues. J Biol Chem. 1992;267:18805\u20139 http:\/\/www.jbc.org\/content\/267\/26\/18805.abstract .","journal-title":"J Biol Chem"},{"key":"5194_CR28","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/S0079-6603(08)60727-8","volume":"63","author":"V Murray","year":"1999","unstructured":"Murray V. A survey of the sequence-specific interaction of damaging agents with DNA: emphasis on antitumor agents. Prog Nucleic Acid Res Mol Biol. 1999;63:367\u2013415 https:\/\/doi.org\/10.1016\/S0079-6603(08)60727-8 .","journal-title":"Prog Nucleic Acid Res Mol Biol"},{"key":"5194_CR29","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s00775-011-0774-y","volume":"16","author":"M Paul","year":"2011","unstructured":"Paul M, Murray V. The sequence selectivity of DNA-targeted 9-aminoacridine cisplatin analogues in a telomere-containing DNA sequence. J Biol Inorg Chem. 2011;16:735\u201343. https:\/\/doi.org\/10.1007\/s00775-011-0774-y .","journal-title":"J Biol Inorg Chem"},{"key":"5194_CR30","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0021-9673(97)00394-4","volume":"806","author":"DL Deforce","year":"1998","unstructured":"Deforce DL, Millecamps RE, Van Hoofstat D, Van den Eeckhout EG. Comparison of slab gel electrophoresis and capillary electrophoresis for the detection of the fluorescently labeled polymerase chain reaction products of short tandem repeat fragments. J Chromatogr A. 1998;806:149\u201355 https:\/\/doi.org\/10.1016\/S0021-9673(97)00394-4 .","journal-title":"J Chromatogr A"},{"key":"5194_CR31","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1021\/ac702265b","volume":"80","author":"EV Fundador","year":"2008","unstructured":"Fundador EV, Choudhary D, Schenkman JB, Rusling JF. Accurate DNA fragment sizing by capillary electrophoresis with laser-induced fluorescence Array for detection of sequence specificity of DNA damage. Anal Chem. 2008;80:2212\u201321. https:\/\/doi.org\/10.1021\/ac702265b .","journal-title":"Anal Chem"},{"key":"5194_CR32","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/bmc.1664","volume":"26","author":"M Paul","year":"2012","unstructured":"Paul M, Murray V. Use of an automated capillary DNA sequencer to investigate the interaction of cisplatin with telomeric DNA sequences. Biomed Chromatogr. 2012;26:350\u20134. https:\/\/doi.org\/10.1002\/bmc.1664 .","journal-title":"Biomed Chromatogr"},{"key":"5194_CR33","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1186\/s12885-016-2368-0","volume":"16","author":"BW Johnson","year":"2016","unstructured":"Johnson BW, Murray V, Temple MD. Characterisation of the DNA sequence specificity, cellular toxicity and cross-linking properties of novel bispyridine-based dinuclear platinum complexes. BMC Cancer. 2016;16:333. https:\/\/doi.org\/10.1186\/s12885-016-2368-0 .","journal-title":"BMC Cancer"},{"key":"5194_CR34","doi-asserted-by":"publisher","first-page":"2772","DOI":"10.1039\/b927129p","volume":"39","author":"AJ Pope","year":"2010","unstructured":"Pope AJ, Bruce C, Kysela B, Hannon MJ. Issues surrounding standard cytotoxicity testing for assessing activity of non-covalent DNA-binding metallo-drugs. Dalton Trans. 2010;39:2772\u20134. https:\/\/doi.org\/10.1039\/b927129p .","journal-title":"Dalton Trans"},{"key":"5194_CR35","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s00775-011-0845-0","volume":"17","author":"T Muchova","year":"2012","unstructured":"Muchova T, Quintal SM, Farrell NP, Brabec V, Kasparkova J. Antitumor bifunctional dinuclear Pt(II) complex BBR3535 forms interduplex DNA cross-links under molecular crowding conditions. J Biol Inorg Chem. 2012;17:239\u201345. https:\/\/doi.org\/10.1007\/s00775-011-0845-0 .","journal-title":"J Biol Inorg Chem"},{"key":"5194_CR36","doi-asserted-by":"publisher","first-page":"3386","DOI":"10.1021\/ja00035a033","volume":"114","author":"MV Keck","year":"1992","unstructured":"Keck MV, Lippard SJ. Unwinding of supercoiled DNA by platinum-ethidium and related complexes. J Am Chem Soc. 1992;114:3386\u201390. https:\/\/doi.org\/10.1021\/ja00035a033 .","journal-title":"J Am Chem Soc"},{"key":"5194_CR37","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0009-2797(97)00110-5","volume":"110","author":"V Murray","year":"1998","unstructured":"Murray V, Whittaker J, McFadyen WD. DNA sequence selectivity of cisplatin analogues in intact human cells. Chem Biol Interact. 1998;110:27\u201337 https:\/\/doi.org\/10.1016\/S0009-2797(97)00110-5 .","journal-title":"Chem Biol Interact"},{"key":"5194_CR38","doi-asserted-by":"publisher","first-page":"8026","DOI":"10.1021\/bi00246a021","volume":"30","author":"SF Bellon","year":"1991","unstructured":"Bellon SF, Coleman JH, Lippard SJ. DNA unwinding produced by site-specific intrastrand cross-links of the antitumor drug cis-diamminedichloroplatinum(II). Biochemistry. 1991;30:8026\u201335. https:\/\/doi.org\/10.1021\/bi00246a021 .","journal-title":"Biochemistry"},{"key":"5194_CR39","doi-asserted-by":"publisher","first-page":"10376","DOI":"10.1039\/c1dt10555h","volume":"40","author":"S Wu","year":"2011","unstructured":"Wu S, Wang X, Zhu C, Song Y, Wang J, Li Y, Guo Z. Monofunctional platinum complexes containing a 4-nitrobenzo-2-oxa-1,3-diazole fluorophore: distribution in tumour cells. Dalton Trans. 2011;40:10376\u201382. https:\/\/doi.org\/10.1039\/c1dt10555h .","journal-title":"Dalton Trans"},{"key":"5194_CR40","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.jinorgbio.2009.06.001","volume":"103","author":"MJ Cairns","year":"2009","unstructured":"Cairns MJ, Carland M, McFadyen WD, Denny WA, Murray V. The DNA sequence selectivity of maltolato-containing cisplatin analogues in purified plasmid DNA and in intact human cells. J Inorg Biochem. 2009;103:1151\u20135. https:\/\/doi.org\/10.1016\/j.jinorgbio.2009.06.001 .","journal-title":"J Inorg Biochem"},{"key":"5194_CR41","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/S0167-4781(97)00087-0","volume":"1354","author":"V Murray","year":"1997","unstructured":"Murray V, Whittaker J, Temple MD, McFadyen WD. Interaction of 11 cisplatin analogues with DNA: characteristic pattern of damage with monofunctional analogues. Biochim Biophys Acta. 1997;1354:261\u201371. https:\/\/doi.org\/10.1016\/S0167-4781(97)00087-0 .","journal-title":"Biochim Biophys Acta"},{"key":"5194_CR42","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1007\/s00775-014-1144-3","volume":"19","author":"HW Kava","year":"2014","unstructured":"Kava HW, Galea AM, Md Jamil F, Feng Y, Murray V. Characterising the atypical 5'-CG DNA sequence specificity of 9-aminoacridine carboxamide Pt complexes. J Biol Inorg Chem. 2014;19:997\u20131007. https:\/\/doi.org\/10.1007\/s00775-014-1144-3 .","journal-title":"J Biol Inorg Chem"},{"key":"5194_CR43","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1158\/1078-0432.CCR-07-2238","volume":"14","author":"LP Martin","year":"2008","unstructured":"Martin LP, Hamilton TC, Schilder RJ. Platinum resistance: the role of DNA repair pathways. Clin Cancer Res. 2008;14:1291. https:\/\/doi.org\/10.1158\/1078-0432.CCR-07-2238 .","journal-title":"Clin Cancer Res"},{"key":"5194_CR44","first-page":"4881","volume":"56","author":"D Fink","year":"1996","unstructured":"Fink D, Nebel S, Aebi S, Zheng H, Cenni B, Nehm\u00e9 A, Christen RD, Howell SB. The role of DNA mismatch repair in platinum drug resistance. Cancer Res. 1996;56:4881 http:\/\/cancerres.aacrjournals.org\/content\/56\/21\/4881 .","journal-title":"Cancer Res"},{"key":"5194_CR45","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1074\/jbc.M105382200","volume":"277","author":"ZZ Zdraveski","year":"2002","unstructured":"Zdraveski ZZ, Mello JA, Farinelli CK, Essigmann JM, Marinus MG. MutS preferentially recognizes cisplatin-over oxaliplatin-modified DNA. J Biol Chem. 2002;277:1255. https:\/\/doi.org\/10.1074\/jbc.M105382200 .","journal-title":"J Biol Chem"},{"key":"5194_CR46","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.ica.2012.06.002","volume":"393","author":"R Olivova","year":"2012","unstructured":"Olivova R, Stepankova J, Muchova T, Novohradsky V, Novakova O, Vrana O, Kasparkova J, Brabec V. Mechanistic insights into toxic effects of a benzotriazolate-bridged dinuclear platinum(II) compound in tumor cells. Inorganica Chim Acta. 2012;393:204\u201311. https:\/\/doi.org\/10.1016\/j.ica.2012.06.002 .","journal-title":"Inorganica Chim Acta"},{"key":"5194_CR47","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.bcp.2009.09.019","volume":"79","author":"J Kasparkova","year":"2010","unstructured":"Kasparkova J, Suchankova T, Halamikova A, Zerzankova L, Vrana O, Margiotta N, Natile G, Brabec V. Cytotoxicity, cellular uptake, glutathione and DNA interactions of an antitumor large-ring PtII chelate complex incorporating the cis-1, 4-diaminocyclohexane carrier ligand. Biochem Pharmacol. 2010;79:552\u201364. https:\/\/doi.org\/10.1016\/j.bcp.2009.09.019 .","journal-title":"Biochem Pharmacol"},{"key":"5194_CR48","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1002\/chem.200701352","volume":"14","author":"J Kasparkova","year":"2008","unstructured":"Kasparkova J, Vojtiskova M, Natile G, Brabec V. Unique properties of DNA Interstrand cross-links of antitumor Oxaliplatin and the effect of chirality of the carrier ligand. Chem Eur J. 2008;14:1330\u201341. https:\/\/doi.org\/10.1002\/chem.200701352 .","journal-title":"Chem Eur J"},{"key":"5194_CR49","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s11243-013-9731-7","volume":"38","author":"E Selimovi\u0107","year":"2013","unstructured":"Selimovi\u0107 E, Vulovi\u0107 T, Petrovi\u0107 B, Bugar\u010di\u0107 \u017d, Bogojeski J. Complex formation reactions of two sterically hindered platinum(II) complexes with some N-bonding ligands. Transit Met Chem. 2013;38:635\u201340. https:\/\/doi.org\/10.1007\/s11243-013-9731-7 .","journal-title":"Transit Met Chem"},{"key":"5194_CR50","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00775-008-0425-0","volume":"14","author":"T Suchankova","year":"2009","unstructured":"Suchankova T, Vojtiskova M, Reedijk J, Brabec V, Kasparkova J. DNA and glutathione interactions in cell-free media of asymmetric platinum(II) complexes cis- and trans-[PtCl2(isopropylamine)(1-methylimidazole)]: relations to their different antitumor effects. J Biol Inorg Chem. 2009;14:75\u201387. https:\/\/doi.org\/10.1007\/s00775-008-0425-0 .","journal-title":"J Biol Inorg Chem"},{"key":"5194_CR51","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1093\/nar\/gkn933","volume":"37","author":"X-M Hou","year":"2009","unstructured":"Hou X-M, Zhang X-H, Wei K-J, Ji C, Dou S-X, Wang W-C, Li M, Wang P-Y. Cisplatin induces loop structures and condensation of single DNA molecules. Nucleic Acids Res. 2009;37:1400\u201310. https:\/\/doi.org\/10.1093\/nar\/gkn933 .","journal-title":"Nucleic Acids Res"},{"key":"5194_CR52","doi-asserted-by":"publisher","first-page":"5152","DOI":"10.1039\/c001158d","volume":"39","author":"P Marques-Gallego","year":"2010","unstructured":"Marques-Gallego P, Gamiz-Gonzalez MA, Fortea-Perez FR, Lutz M, Spek A, Pevec A, Kozlevcar B, Reedijk J. Quinoxaline-2-carboxamide as a carrier ligand in two new platinum(II) compounds: synthesis, crystal structure, cytotoxic activity and DNA interaction. Dalton Trans. 2010;39:5152\u20138. https:\/\/doi.org\/10.1039\/c001158d .","journal-title":"Dalton Trans"},{"key":"5194_CR53","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jinorgbio.2011.09.025","volume":"108","author":"T Suchankova","year":"2012","unstructured":"Suchankova T, Kubicek K, Kasparkova J, Brabec V, Kozelka J. Platinum-DNA interstrand crosslinks: molecular determinants of bending and unwinding of the double helix. J Inorg Biochem. 2012;108:69\u201379. https:\/\/doi.org\/10.1016\/j.jinorgbio.2011.09.025 .","journal-title":"J Inorg Biochem"},{"key":"5194_CR54","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1007\/s00775-013-1022-4","volume":"18","author":"E Gabano","year":"2013","unstructured":"Gabano E, Gama S, Mendes F, Gariboldi M, Monti E, Bombard S, Bianco S, Ravera M. Study of the synthesis, antiproliferative properties, and interaction with DNA and polynucleotides of cisplatin-like Pt(II) complexes containing carcinogenic polyaromatic amines. J Biol Inorg Chem. 2013;18:791\u2013801. https:\/\/doi.org\/10.1007\/s00775-013-1022-4 .","journal-title":"J Biol Inorg Chem"},{"key":"5194_CR55","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.jinorgbio.2012.03.003","volume":"112","author":"Y Sun","year":"2012","unstructured":"Sun Y, Yin R, Gou S, Zhaojian. Antitumor platinum(II) complexes of N-monoalkyl-1R, 2R-diaminocyclohexane derivatives with alkyl groups as hindrance. J Inorg Biochem. 2012;112:68\u201376. https:\/\/doi.org\/10.1016\/j.jinorgbio.2012.03.003 .","journal-title":"J Inorg Biochem"},{"key":"5194_CR56","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1007\/s10637-010-9461-z","volume":"29","author":"J Moretto","year":"2011","unstructured":"Moretto J, Chauffert B, Ghiringhelli F, Aldrich-Wright JR, Bouyer F. Discrepancy between in vitro and in vivo antitumor effect of a new platinum(II) metallointercalator. Investig New Drugs. 2011;29:1164\u201376. https:\/\/doi.org\/10.1007\/s10637-010-9461-z .","journal-title":"Investig New Drugs"},{"key":"5194_CR57","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1039\/C2DT31323E","volume":"42","author":"KB Garbutcheon-Singh","year":"2013","unstructured":"Garbutcheon-Singh KB, Leverett P, Myers S, Aldrich-Wright JR. Cytotoxic platinum(ii) intercalators that incorporate 1R,2R-diaminocyclopentane. Dalton Trans. 2013;42:918\u201326. https:\/\/doi.org\/10.1039\/C2DT31323E .","journal-title":"Dalton Trans"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-5194-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-018-5194-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-5194-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T19:47:36Z","timestamp":1662666456000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-018-5194-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["5194"],"URL":"https:\/\/doi.org\/10.1186\/s12885-018-5194-8","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"19 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable. However, we wish to acknowledge that in 1951 HeLa cells were taken without consent from Henrietta Lacks and we thank the Lacks family for their generous contributions to the biomedical community.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"1284"}}